Purchase Order DJBP0203SB130168
Award Date 6/8/17
Potential Completion Date 6/28/17
Potential Value $5.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Danbury, CT 06811, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Defense Logistics Agency awarded a $906 firm fixed price delivery order to Amerisourcebergen Drug Corp for RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML. As the parent company, Amerisourcebergen Corporation will perform through its Corporate Office location in Conshohocken, Pennsylvania. This order was issued against an unspecified governmentwide acquisition contract vehicle and provides 4562521156 units of the specified pharmaceutical to meet Defense Logistics Agency requirements. Delivery is required...
- The Defense Logistics Agency awarded a $8,942 delivery order to Amerisourcebergen Drug Corporation for 30 boxes of 1 mg REXULTI tablets each containing 30 pills under firm fixed price terms. The order is to be fulfilled from Amerisourcebergen's facility located in Conshohocken, Pennsylvania by August 7, 2023 to support the Defense Logistics Agency's medical supply needs. No set aside designation or subcontractors were identified. The Defense Logistics Agency manages the global supply chain for...
- This delivery order for REXULTI 2 MG tablets was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation, located in Conshohocken, Pennsylvania. The firm fixed price order, valued at eight hundred sixty dollars, requires the delivery of 30 tablets by October 11, 2023. No set-aside provision was applied to this order under the DLA's pharmaceutical supply program. Amerisourcebergen will fulfill the order from its corporate headquarters, delivering the requested pharmaceutical...
- The Defense Logistics Agency awarded a $239,850 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. The prime contractor will deliver 2.5ml bottles of the glaucoma medication to the DLA under this single day contract ending June 23, 2023. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were specified. The DLA manages the Department of Defense's global...
- The Defense Logistics Agency Troop Support Medical awarded a $3,402.50 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for 1,000 milligram Ranexa extended release tablets. Under the contract, Amerisourcebergen will deliver 60 tablets to a location in Conshohocken, Pennsylvania by July 21, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, and this delivery order was awarded under an existing...
- The Defense Logistics Agency awarded a $995 delivery order to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. The firm fixed price order is valued at approximately one thousand dollars to supply the 2.5mL ophthalmic solution. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two day period in early September 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency routinely contracts for...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the prescription medication REXULTI 2 MG TABLET 30S, with a ceiling value of $4,874.10 and a period of performance ending on July 2, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,249,991 units of the pharmaceutical product REXULTI 2 MG TABLET 30S. The $16,052.19 delivery order has a completion date of January 8, 2024. Amerisourcebergen Drug Corp, a for-profit organization, regularly provides pharmaceutical products and medical supplies to support DLA programs from its...
- The Defense Logistics Agency awarded a $575.54 delivery order to Amerisourcebergen Drug Corporation for RHOPRESSA 0.02% ophthalmic solution. The firm fixed price order is being fulfilled under the Prime Vendor Program contract vehicle and calls for the delivery of 2.5ml bottles of the glaucoma drug to a facility in Conshohocken, Pennsylvania. Performance will take place between August 18-21, 2023. No subcontractors or set aside designations were specified. The order supports the DLA's medical...
- The Defense Logistics Agency awarded a $906.36 firm fixed price delivery order to Amerisourcebergen Drug Corporation for RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML. The prime contractor will deliver the specified pharmaceutical product to a location in Conshohocken, Pennsylvania by August 24, 2023 in support of DLA programs. No major subcontractors or set aside designations were indicated. DLA manages the global supply chain for the United States Department of Defense, procuring critical medical...